Teva Pharmaceuticals To Expand in Canada With $6M Grant
05/28/2010
"Teva's high potent product manufacturing facility expansion in Stouffville, Ontario will enable use to secure Canadian and export mandates for high-quality, value-priced generic medicines," said Barry Fishman, president and CEO of Teva Canada Limited. "This partnership with the Ontario government to construct an advanced manufacturing facility will increase Teva Canada's capabilities and capacity and allow us to retain and grow high-value jobs in Ontario."
The same day the expansion was announced, Ontario Premier Dalton McGuinty met with scientists from Israel's Weizman Institute of Science to discuss new partnership opportunities. Among the Institute's research are ways to eliminate famine.
"Teva Pharmaceuticals is a perfect example of the kind of partner we're looking for in Israel," McGuinty said.
Most Read
-
-
What’s Driving Record Industrial Real Estate Demand
Q1 2021
-
2020 Top States for Doing Business Showcase Their Pro-Business Environments
Q3 2020
-
2020 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Q2 2020
-
Pandemic Fuels Data Center Growth
Q1 2021
-
Trends in Office and Industrial Parks
Q4 2020
-
35th Annual Survey of Corporate Executives Commentary: Change in Site Selection Priorities and Plans Over the Short and Long Term
Q1 2021